Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes

This is the authors' abstract. We don't add key points for this paper.

Evidence showed that financial burdens are common, disproportionately impacting younger and socioeconomically disadvantaged patients with cancer, across disease sites, and are associated with worse treatment adherence and HRQoL. Available evidence helped identify vulnerable patients needing oncology provider engagement and response, but evidence is critically needed on the effectiveness of interventions designed to mitigate financial burden and impact.